Pyridam Farma acquires IDR 120 billion loan from Bank Mandiri, what will it be used for?
03 Feb 2025 09:58
Based on the agreement, the interest rate is set to 8.25% per annum, with repayment period of 96 months from the signing date.
Pyridam Farma’s loss worsened to IDR 214.2 billion in 9M 2024
04 Nov 2024 06:04
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company, booked net loss of IDR 214.2 billion in the first nine months (9M) 2024.
PYFA subsidiary secures US$ 15 million loan from HSBC
19 Jul 2024 09:51
One of the subsidiaries of PT Pyridam Farma Tbk (PYFA), namely Pyfa Health Singapore Pte. Ltd. (Pyfa Singapore), has obtained a credit facility worth US$ 15 million or around IDR 242.6 billion.
Acquiring Probiotec, PYFA’s subsidiary receives IDR 1.07 trillion
12 Jun 2024 09:25
PYFA Australia Pty Ltd (PAPL), an entity under PT Pyridam Farma Tbk (PYFA), has secured extra capital of USD 99.57 million or equal to approximately IDR 1.07 trillion.
Pyridam Farma eyes IDR 400 billion through bonds’ issuance
26 Jan 2024 09:26
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company under Rejuve Global Investment, will issue its Shelf-Registration Bonds I of PYFA Phase III Year 2024, with a total principal of IDR 400 billion.
PYFA granted approval from shareholders to offer 16 billion shares in rights issue
09 Jan 2024 09:42
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company operating since 1997, has managed to obtained approval during the Extraordinary General Meeting of Shareholders regarding the rights issue.